SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness

SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19 patients. We analyzed 625 serial plasma samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Röltgen, Katharina, Wirz, Oliver F., Stevens, Bryan A., Powell, Abigail E., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Nadeau, Kari C., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Kim, Peter S., Gombar, Saurabh, Tibshirani, Robert, Pinsky, Benjamin A., Boyd, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444305/
https://www.ncbi.nlm.nih.gov/pubmed/32839786
http://dx.doi.org/10.1101/2020.08.15.20175794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444305/
https://www.ncbi.nlm.nih.gov/pubmed/32839786
http://dx.doi.org/10.1101/2020.08.15.20175794

Ejemplares similares